Top 5 Turnaround Companies In Q1FY14
After the results season for the first quarter of FY14, in our last two slideshows we have looked at companies which have posted a consistent rise and fall respectively in their PAT levels in the last four quarters. Here, we take a look at companies which have managed to see a turnaround in their performance during Q1FY14 on a YoY basis.
We have sifted out the companies on the basis of their market capitalisation, taking into consideration only those with a market cap of over Rs 150 crore.
| Company Name | PAT Q1FY14 (Rs Cr) | PAT Q1FY13 (Rs Cr) | Latest Mcap (Rs Cr) | YTD Returns (%) |
|---|
| Cairn India | 1989.12 | -33.88 | 57538.94 | -6.23 |
| Essar Oil | 200.00 | -515.00 | 7483.86 | -23.30 |
| Aurobindo Pharma | 143.63 | -49.84 | 5262.19 | -6.52 |
| GMR Infrastructure | 71.43 | -38.52 | 5005.67 | -36.81 |
| Max India | 15.74 | -1.39 | 4951.73 | -24.00 |
Source: Accord Fintech
Cairn India: Cairn India is a part of the Vedanta Group and is one of the largest private exploration and production companies currently operating in the country. The company has been operating in India for over 15 years and has played an active role in developing the oil & gas resources here. Ravva in eastern India was the first offshore oil and gas field to be developed by Cairn India. This was followed by the Lakshmi gas field in western India, which was discovered in 2000 and commenced production in 2002.
In the recently concluded quarter, the company has made a turnaround in terms of its PAT levels. During the period, it posted a net profit of Rs 1989 crore as against a loss of Rs 33.88 crore for the same quarter last fiscal. On a YTD basis, the stock has yielded negative returns of 6.23%.
Essar Oil: Essar Oil has a global portfolio of onshore and offshore oil & gas blocks, with about 35000 sq. km available for exploration. The company has over 750000 bpsd (barrels per stream day) of global crude-refining capacity. As for marketing, the company operates a network of over 1400 retail outlets across India, with another 200 under various stages of commissioning.
The company was in the red in Q1FY13, posting a loss of Rs 515 crore. In Q1FY14, though, it was able to turn into the black and post a profit of Rs 200 crore. On a YTD basis, the stock prices have declined by 23.30%.
Aurobindo Pharma: Aurobindo Pharma commenced operations in 1988-89, with a single unit manufacturing of Semi-Synthetic Penicillin (SSP) at Pondicherry.
In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovasculars, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
On a YTD basis the stock has yielded a negative return of 6.52%. It posted a loss Rs 49.84 crore during Q1FY13, but managed to turn around in Q1FY14, with a PAT of Rs 143.63 crore.
GMR Infrastructure: GMR Infrastructure is an infrastructure holding company formed to fund the capital requirements of various infrastructure projects across sectors. It undertakes the development of infra projects through its various subsidiaries.
The company posted a loss of Rs 38.52 crore for Q1FY13, but registered a profit of Rs 71.43 crore in Q1FY14. On a YTD basis, the stock prices have declined by 36.81%.
Max India: Max India, through its subsidiaries, engages in the life and health insurance, clinical research, healthcare and senior living businesses in India and internationally.
On a YTD basis, the stock has given negative return of 24%. Though it saw a loss Rs 1.39 crore in Q1FY13, it saw a better performance in Q1FY14, posting a PAT of Rs 15.74 crore.